Australian researchers achieve a breakthrough in improving breast cancer cure rates, offering new hope for patients worldwide.
Vous n'êtes pas connecté
In breast cancer patients, adding the immunotherapy drug nivolumab to pre-surgery chemotherapy can significantly enhance patient outcomes, as highlighted
Australian researchers achieve a breakthrough in improving breast cancer cure rates, offering new hope for patients worldwide.
The FDA's nod is based on late-stage data, which show AZN's Datroway cuts the risk of disease progression/death by 37% vs chemotherapy in certain...
Weill Cornell Medicine, USA, has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable...
FRIDAY, Jan. 24, 2025 -- Patients can improve their odds for a successful surgery by actively preparing for the procedure through diet and exercise, a...
FRIDAY, Jan. 24, 2025 -- Patients can improve their odds for a successful surgery by actively preparing for the procedure through diet and exercise, a...
An international team of UK and US scientists has discovered that the activity of macrophages – a type of white blood cell that engulfs pathogens...
THURSDAY, Jan. 16, 2025 -- For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab...
The results of a VHIO-led study published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR), underscore...
An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate...
A recent study published in JAMA Surgery reveals a surprising connection between surgeon stress at the start of a procedure and patient outcomes....